These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 11950447)
1. Comparison of effects of carvedilol versus metoprolol on cytokine levels in patients with idiopathic dilated cardiomyopathy. Ohtsuka T; Hamada M; Saeki H; Ogimoto A; Hiasa Go; Hara Y; Shigematsu Y; Hiwada K Am J Cardiol; 2002 Apr; 89(8):996-9. PubMed ID: 11950447 [No Abstract] [Full Text] [Related]
2. Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy. Kurum T; Tatli E; Yuksel M Tex Heart Inst J; 2007; 34(1):52-9. PubMed ID: 17420794 [TBL] [Abstract][Full Text] [Related]
3. Effects of different degrees of sympathetic antagonism on cytokine network in patients with ischemic dilated cardiomyopathy. Cinquegrana G; D'Aniello L; Landi M; Spinelli L; Grande G; De Prisco F; Petretta M J Card Fail; 2005 Apr; 11(3):213-9. PubMed ID: 15812750 [TBL] [Abstract][Full Text] [Related]
4. Found in translation: metoprolol improves survival more than carvedilol in a mouse model of inherited dilated cardiomyopathy. Aguilar-Torres R Cardiovasc Res; 2009 Oct; 84(1):7-8. PubMed ID: 19648169 [No Abstract] [Full Text] [Related]
5. What type of beta-blocker should be used to treat chronic heart failure? Bristow MR Circulation; 2000 Aug; 102(5):484-6. PubMed ID: 10920055 [No Abstract] [Full Text] [Related]
6. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy. Tatli E; Kurum T Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561 [TBL] [Abstract][Full Text] [Related]
7. Effects of carvedilol on plasma levels of interleukin-6 and tumor necrosis factor-alpha in nine patients with dilated cardiomyopathy. Matsumura T; Tsushima K; Ohtaki E; Misu K; Tohbaru T; Asano R; Nagayama M; Kitahara K; Umemura J; Sumiyoshi T; Hosoda S J Cardiol; 2002 May; 39(5):253-7. PubMed ID: 12048901 [TBL] [Abstract][Full Text] [Related]
8. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group. Di Lenarda A; Sabbadini G; Salvatore L; Sinagra G; Mestroni L; Pinamonti B; Gregori D; Ciani F; Muzzi A; Klugmann S; Camerini F J Am Coll Cardiol; 1999 Jun; 33(7):1926-34. PubMed ID: 10362195 [TBL] [Abstract][Full Text] [Related]
9. Serum levels of matrix metalloproteinases and tumor necrosis factor-alpha in patients with idiopathic dilated cardiomyopathy and effect of carvedilol on these levels. Ohtsuka T; Hamada M; Saeki H; Ogimoto A; Hara Y; Shigematsu Y; Higaki J Am J Cardiol; 2003 Apr; 91(8):1024-7, A8. PubMed ID: 12686357 [No Abstract] [Full Text] [Related]
10. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Metra M; Giubbini R; Nodari S; Boldi E; Modena MG; Dei Cas L Circulation; 2000 Aug; 102(5):546-51. PubMed ID: 10920067 [TBL] [Abstract][Full Text] [Related]
11. The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy. Nikolaidis LA; Poornima I; Parikh P; Magovern M; Shen YT; Shannon RP J Am Coll Cardiol; 2006 May; 47(9):1871-81. PubMed ID: 16682315 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of beta-blockers on left ventricular dyssynchrony and reverse remodeling in idiopathic dilated cardiomyopathy: A randomized trial of carvedilol and metoprolol. Kaya MG; Sarli B; Akpek M; Kaya EG; Yarlioglues M; Topsakal R; Lam YY Cardiol J; 2014; 21(4):434-41. PubMed ID: 24142686 [TBL] [Abstract][Full Text] [Related]
13. Second- and third-generation beta-blocking drugs in chronic heart failure. Bristow MR; Abraham WT; Yoshikawa T; White M; Hattler BG; Crisman TS; Lowes BD; Robertson AD; Larrabee P; Gilbert EM Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():291-6. PubMed ID: 9211023 [TBL] [Abstract][Full Text] [Related]
14. [Is "COMET" pointing in the right direction?--Pro]. Hanrath P Dtsch Med Wochenschr; 2003 Dec; 128(50):2666. PubMed ID: 14673747 [No Abstract] [Full Text] [Related]
15. [Is "COMET" pointing in the right direction?--Con]. Schneider CA Dtsch Med Wochenschr; 2003 Dec; 128(50):2667. PubMed ID: 14673748 [No Abstract] [Full Text] [Related]
16. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Gilbert EM; Abraham WT; Olsen S; Hattler B; White M; Mealy P; Larrabee P; Bristow MR Circulation; 1996 Dec; 94(11):2817-25. PubMed ID: 8941107 [TBL] [Abstract][Full Text] [Related]
17. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. Lee YC Am J Cardiol; 1997 Apr; 79(7):1001. PubMed ID: 9104927 [No Abstract] [Full Text] [Related]
18. Long-term effects of carvedilol or metoprolol on left ventricular function in ischemic and nonischemic cardiomyopathy. Green P; Anshelevich M; Talreja A; Burcham JL; Ravi SM; Shirani J; Le Jemtel TH Am J Cardiol; 2005 May; 95(9):1114-6. PubMed ID: 15842987 [TBL] [Abstract][Full Text] [Related]
19. [New milestones in the therapy of chronic heart failure with beta blockers]. Garlichs C; Daniel WG Z Kardiol; 2000 Mar; 89(3):236-8. PubMed ID: 10798280 [No Abstract] [Full Text] [Related]